Congestive Heart Failure Drugs Market Size to Cross USD 13.5 Bn Revenue by 2031 | TMR Study Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The global congestive heart failure drugs market was valued at USD 6.7 Bn in 2022 and is estimated to reach USD 13.5 Bn by...

Eagle Pharmaceuticals Announces Submission of New Drug Application to U.S. Food and Drug Administration for Landiolol, a Beta-1 Adrenergic Blocker -- Submission seeks approval for landiolol for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter -- --...

Franciosi Consulting Investigating Beta-Adrenergic Receptor Antagonists as Potential New Treatments for Essential Tremor VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Franciosi Consulting Ltd. will be performing structure activity analyses of published beta-adrenergic receptor antagonists (a.k.a. beta...